SNOQUALMIE, Wash.–(BUSINESS WIRE)–#acc22–Spacelabs Healthcare, a division of OSI Systems, Inc. (“OSI Systems”), today announced that it will be demonstrating new diagnostic cardiology products at the American College of Cardiology’s (“ACC”) 71st annual event.
Attendees will have an opportunity to see new and recent offerings from Spacelabs Healthcare, including the Eclipse™ Pro extended Holter recorder and the Lifescreen™ Pro rapid analysis screening system. The CardioPulse™ line of fully featured 12-lead cardiographs with full DICOM and HL-7 connectivity will be available for demonstration.
Eclipse Pro provides cardiologists a versatile choice for screening, arrhythmia, pacemaker detection, and 12-lead ECG. The device is designed for patient comfort to increase patient compliance, which can result in better quality recordings. The Eclipse Pro can record up to 14 days of 3-lead ECG or 3 days of 12-lead ECG for analysis providing the ability to perform 24 to 48 hour Holter or up to 14 days of extended Holter. Once the recording is complete, Lifescreen Pro provides rapid analysis, allowing an initial triage to find suspected or intermittent arrhythmia events. Utilizing Eclipse Pro and Lifescreen Pro together can facilitate triaging of recordings and quickly identify patients in need of further diagnosis and treatment, including atrial fibrillation.
CardioPulse cardiographs are designed for efficiency even in the most acute settings. A bi-directional DICOM option into existing EMR or PACS systems and the ability to review, store, and transmit rhythm strips for up to 10 minutes means a seamless fit into clinical workflows.
“These products represent a new milestone in patient care,” said Spacelabs Healthcare President Shalabh Chandra. “By quickly presenting a clear picture of the patient’s condition, cardiologists are better able to ensure their patients continue on the right care pathway as soon as possible.”
About Spacelabs Healthcare
Spacelabs Healthcare (www.spacelabshealthcare.com), a division of OSI Systems, is a provider of medical equipment and services, including solutions for patient monitoring and connectivity, non-invasive cardiology, and supplies and accessories selling to hospitals, clinics, and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, and Italy, and distributors in more than 100 countries around the world.
About OSI Systems
OSI Systems is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense, and aerospace industries. OSI Systems combines more than 40 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end product markets. For more information on OSI Systems or its subsidiary companies, visit www.osi-systems.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to OSI Systems’ current expectations, beliefs, and projections concerning matters that are not historical facts. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions, and contingencies, many of which are outside OSI Systems’ control and which may cause actual results to differ materially from those described in or implied by any forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are based on currently available information and speak only as of the date on which they are made. OSI Systems assumes no obligation to update any forward-looking statement made in this press release that becomes untrue because of subsequent events, new information, or otherwise, except to the extent it is required to do so in connection with its ongoing requirements under Federal securities laws. For a further discussion of factors that could cause OSI Systems’ future results to differ materially from any forward-looking statements, see the section entitled “Risk Factors” in OSI Systems’ most recently filed Annual Report on Form 10-K and other risks described therein and in documents subsequently filed by OSI Systems from time to time with the Securities and Exchange Commission.
Contacts
Spacelabs Healthcare
Paul Sogge, 425-363-5592